nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0175	0.066	CbGeAlD
Quetiapine—Subdural haematoma—Riluzole—amyotrophic lateral sclerosis	0.0167	0.0251	CcSEcCtD
Quetiapine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0113	0.0426	CbGeAlD
Quetiapine—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00979	0.0147	CcSEcCtD
Quetiapine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.00947	0.0358	CbGeAlD
Quetiapine—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00939	0.0141	CcSEcCtD
Quetiapine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.00917	0.0346	CbGeAlD
Quetiapine—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00902	0.0136	CcSEcCtD
Quetiapine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00885	0.0133	CcSEcCtD
Quetiapine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00823	0.0124	CcSEcCtD
Quetiapine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0073	0.0276	CbGeAlD
Quetiapine—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00724	0.0109	CcSEcCtD
Quetiapine—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00724	0.0109	CcSEcCtD
Quetiapine—HTR7—pons—amyotrophic lateral sclerosis	0.00722	0.0273	CbGeAlD
Quetiapine—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0104	CcSEcCtD
Quetiapine—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0104	CcSEcCtD
Quetiapine—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0104	CcSEcCtD
Quetiapine—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00665	0.01	CcSEcCtD
Quetiapine—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00962	CcSEcCtD
Quetiapine—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00632	0.00949	CcSEcCtD
Quetiapine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00938	CcSEcCtD
Quetiapine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00938	CcSEcCtD
Quetiapine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00926	CcSEcCtD
Quetiapine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00926	CcSEcCtD
Quetiapine—DRD1—nerve—amyotrophic lateral sclerosis	0.00599	0.0226	CbGeAlD
Quetiapine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00595	0.00894	CcSEcCtD
Quetiapine—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00884	CcSEcCtD
Quetiapine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00874	CcSEcCtD
Quetiapine—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00874	CcSEcCtD
Quetiapine—HTR3A—nerve—amyotrophic lateral sclerosis	0.00579	0.0218	CbGeAlD
Quetiapine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00864	CcSEcCtD
Quetiapine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00569	0.00855	CcSEcCtD
Quetiapine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00836	CcSEcCtD
Quetiapine—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00836	CcSEcCtD
Quetiapine—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00802	CcSEcCtD
Quetiapine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00779	CcSEcCtD
Quetiapine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00771	CcSEcCtD
Quetiapine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00771	CcSEcCtD
Quetiapine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00771	CcSEcCtD
Quetiapine—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00508	0.00764	CcSEcCtD
Quetiapine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00508	0.00764	CcSEcCtD
Quetiapine—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00757	CcSEcCtD
Quetiapine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00499	0.0075	CcSEcCtD
Quetiapine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00743	CcSEcCtD
Quetiapine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00743	CcSEcCtD
Quetiapine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00743	CcSEcCtD
Quetiapine—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00736	CcSEcCtD
Quetiapine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00736	CcSEcCtD
Quetiapine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00485	0.00729	CcSEcCtD
Quetiapine—Mania—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00723	CcSEcCtD
Quetiapine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.0048	0.0181	CbGeAlD
Quetiapine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00704	CcSEcCtD
Quetiapine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00698	CcSEcCtD
Quetiapine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00698	CcSEcCtD
Quetiapine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00456	0.0172	CbGeAlD
Quetiapine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00681	CcSEcCtD
Quetiapine—HTR2A—pons—amyotrophic lateral sclerosis	0.0045	0.017	CbGeAlD
Quetiapine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00675	CcSEcCtD
Quetiapine—HTR1E—brainstem—amyotrophic lateral sclerosis	0.00441	0.0166	CbGeAlD
Quetiapine—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00649	CcSEcCtD
Quetiapine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00639	CcSEcCtD
Quetiapine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00634	CcSEcCtD
Quetiapine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00611	CcSEcCtD
Quetiapine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00598	CcSEcCtD
Quetiapine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00594	CcSEcCtD
Quetiapine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00586	CcSEcCtD
Quetiapine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00578	CcSEcCtD
Quetiapine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00384	0.0145	CbGeAlD
Quetiapine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00574	CcSEcCtD
Quetiapine—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00574	CcSEcCtD
Quetiapine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0057	CcSEcCtD
Quetiapine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00567	CcSEcCtD
Quetiapine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00563	CcSEcCtD
Quetiapine—HTR7—nerve—amyotrophic lateral sclerosis	0.00374	0.0141	CbGeAlD
Quetiapine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00559	CcSEcCtD
Quetiapine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00556	CcSEcCtD
Quetiapine—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00552	CcSEcCtD
Quetiapine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00539	CcSEcCtD
Quetiapine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00535	CcSEcCtD
Quetiapine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00532	CcSEcCtD
Quetiapine—DRD2—nerve—amyotrophic lateral sclerosis	0.00354	0.0134	CbGeAlD
Quetiapine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00352	0.0133	CbGeAlD
Quetiapine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00526	CcSEcCtD
Quetiapine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00526	CcSEcCtD
Quetiapine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00526	CcSEcCtD
Quetiapine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0052	CcSEcCtD
Quetiapine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0052	CcSEcCtD
Quetiapine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00513	CcSEcCtD
Quetiapine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00508	CcSEcCtD
Quetiapine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00508	CcSEcCtD
Quetiapine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00502	CcSEcCtD
Quetiapine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00329	0.0124	CbGeAlD
Quetiapine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00483	CcSEcCtD
Quetiapine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00475	CcSEcCtD
Quetiapine—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00475	CcSEcCtD
Quetiapine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00461	CcSEcCtD
Quetiapine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00456	CcSEcCtD
Quetiapine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00452	CcSEcCtD
Quetiapine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00299	0.0113	CbGeAlD
Quetiapine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00447	CcSEcCtD
Quetiapine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00447	CcSEcCtD
Quetiapine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00293	0.0111	CbGeAlD
Quetiapine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00439	CcSEcCtD
Quetiapine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00439	CcSEcCtD
Quetiapine—H1F0—embryo—amyotrophic lateral sclerosis	0.00284	0.0107	CbGeAlD
Quetiapine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00427	CcSEcCtD
Quetiapine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00425	CcSEcCtD
Quetiapine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.0028	0.0106	CbGeAlD
Quetiapine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00421	CcSEcCtD
Quetiapine—Injury—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00415	CcSEcCtD
Quetiapine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00412	CcSEcCtD
Quetiapine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0027	0.0102	CbGeAlD
Quetiapine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00406	CcSEcCtD
Quetiapine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00406	CcSEcCtD
Quetiapine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00404	CcSEcCtD
Quetiapine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00403	CcSEcCtD
Quetiapine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00401	CcSEcCtD
Quetiapine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00265	0.01	CbGeAlD
Quetiapine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00393	CcSEcCtD
Quetiapine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00257	0.00971	CbGeAlD
Quetiapine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00383	CcSEcCtD
Quetiapine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00382	CcSEcCtD
Quetiapine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00379	CcSEcCtD
Quetiapine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00376	CcSEcCtD
Quetiapine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00376	CcSEcCtD
Quetiapine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00248	0.00938	CbGeAlD
Quetiapine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00373	CcSEcCtD
Quetiapine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00368	CcSEcCtD
Quetiapine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00363	CcSEcCtD
Quetiapine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00363	CcSEcCtD
Quetiapine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00361	CcSEcCtD
Quetiapine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00359	CcSEcCtD
Quetiapine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00355	CcSEcCtD
Quetiapine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00233	0.00882	CbGeAlD
Quetiapine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00349	CcSEcCtD
Quetiapine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00347	CcSEcCtD
Quetiapine—HTR1E—nervous system—amyotrophic lateral sclerosis	0.00231	0.00872	CbGeAlD
Quetiapine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00345	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00344	CcSEcCtD
Quetiapine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00338	CcSEcCtD
Quetiapine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00337	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00337	CcSEcCtD
Quetiapine—HTR1E—central nervous system—amyotrophic lateral sclerosis	0.00222	0.00839	CbGeAlD
Quetiapine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00332	CcSEcCtD
Quetiapine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0033	CcSEcCtD
Quetiapine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0033	CcSEcCtD
Quetiapine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0033	CcSEcCtD
Quetiapine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00323	CcSEcCtD
Quetiapine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00321	CcSEcCtD
Quetiapine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00317	CcSEcCtD
Quetiapine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00316	CcSEcCtD
Quetiapine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00208	0.00787	CbGeAlD
Quetiapine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00308	CcSEcCtD
Quetiapine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00308	CcSEcCtD
Quetiapine—DRD4—brain—amyotrophic lateral sclerosis	0.00205	0.00773	CbGeAlD
Quetiapine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00305	CcSEcCtD
Quetiapine—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00202	0.00764	CbGeAlD
Quetiapine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00304	CcSEcCtD
Quetiapine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00202	0.00762	CbGeAlD
Quetiapine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.002	0.00301	CcSEcCtD
Quetiapine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.002	0.00754	CbGeAlD
Quetiapine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.002	0.003	CcSEcCtD
Quetiapine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00298	CcSEcCtD
Quetiapine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00296	CcSEcCtD
Quetiapine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00294	CcSEcCtD
Quetiapine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00294	CcSEcCtD
Quetiapine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00293	CcSEcCtD
Quetiapine—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00195	0.00736	CbGeAlD
Quetiapine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00287	CcSEcCtD
Quetiapine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00287	CcSEcCtD
Quetiapine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00286	CcSEcCtD
Quetiapine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00188	0.00711	CbGeAlD
Quetiapine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00282	CcSEcCtD
Quetiapine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00278	CcSEcCtD
Quetiapine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00277	CcSEcCtD
Quetiapine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00276	CcSEcCtD
Quetiapine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00274	CcSEcCtD
Quetiapine—H1F0—medulla oblongata—amyotrophic lateral sclerosis	0.00182	0.00686	CbGeAlD
Quetiapine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00181	0.00684	CbGeAlD
Quetiapine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00181	0.00684	CbGeAlD
Quetiapine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00269	CcSEcCtD
Quetiapine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00265	CcSEcCtD
Quetiapine—HTR1E—brain—amyotrophic lateral sclerosis	0.00176	0.00666	CbGeAlD
Quetiapine—DRD5—nervous system—amyotrophic lateral sclerosis	0.00176	0.00666	CbGeAlD
Quetiapine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00265	CcSEcCtD
Quetiapine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00264	CcSEcCtD
Quetiapine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00264	CcSEcCtD
Quetiapine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00175	0.0066	CbGeAlD
Quetiapine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00263	CcSEcCtD
Quetiapine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00263	CcSEcCtD
Quetiapine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00174	0.00659	CbGeAlD
Quetiapine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00262	CcSEcCtD
Quetiapine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00261	CcSEcCtD
Quetiapine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0026	CcSEcCtD
Quetiapine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00259	CcSEcCtD
Quetiapine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00259	CcSEcCtD
Quetiapine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.0017	0.00641	CbGeAlD
Quetiapine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00168	0.00635	CbGeAlD
Quetiapine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0025	CcSEcCtD
Quetiapine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00247	CcSEcCtD
Quetiapine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00245	CcSEcCtD
Quetiapine—H1F0—spinal cord—amyotrophic lateral sclerosis	0.00162	0.00612	CbGeAlD
Quetiapine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00161	0.00607	CbGeAlD
Quetiapine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0024	CcSEcCtD
Quetiapine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00159	0.00602	CbGeAlD
Quetiapine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00238	CcSEcCtD
Quetiapine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00238	CcSEcCtD
Quetiapine—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00158	0.00597	CbGeAlD
Quetiapine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00237	CcSEcCtD
Quetiapine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00155	0.00585	CbGeAlD
Quetiapine—CHRM4—brain—amyotrophic lateral sclerosis	0.00155	0.00584	CbGeAlD
Quetiapine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00231	CcSEcCtD
Quetiapine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0023	CcSEcCtD
Quetiapine—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00152	0.00575	CbGeAlD
Quetiapine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00152	0.00574	CbGeAlD
Quetiapine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00226	CcSEcCtD
Quetiapine—Tension—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00226	CcSEcCtD
Quetiapine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00225	CcSEcCtD
Quetiapine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00223	CcSEcCtD
Quetiapine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00222	CcSEcCtD
Quetiapine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00221	CcSEcCtD
Quetiapine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00145	0.00546	CbGeAlD
Quetiapine—DRD3—brain—amyotrophic lateral sclerosis	0.00144	0.00543	CbGeAlD
Quetiapine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00215	CcSEcCtD
Quetiapine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00213	CcSEcCtD
Quetiapine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00141	0.00534	CbGeAlD
Quetiapine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00212	CcSEcCtD
Quetiapine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00211	CcSEcCtD
Quetiapine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0021	CcSEcCtD
Quetiapine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00139	0.00526	CbGeAlD
Quetiapine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00526	CbGeAlD
Quetiapine—HTR6—brain—amyotrophic lateral sclerosis	0.00138	0.00523	CbGeAlD
Quetiapine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00207	CcSEcCtD
Quetiapine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00206	CcSEcCtD
Quetiapine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00206	CcSEcCtD
Quetiapine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00206	CcSEcCtD
Quetiapine—H1F0—nervous system—amyotrophic lateral sclerosis	0.00136	0.00515	CbGeAlD
Quetiapine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00514	CbGeAlD
Quetiapine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00203	CcSEcCtD
Quetiapine—DRD5—brain—amyotrophic lateral sclerosis	0.00135	0.00509	CbGeAlD
Quetiapine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00135	0.00509	CbGeAlD
Quetiapine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00202	CcSEcCtD
Quetiapine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00201	CcSEcCtD
Quetiapine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00199	CcSEcCtD
Quetiapine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00198	CcSEcCtD
Quetiapine—H1F0—central nervous system—amyotrophic lateral sclerosis	0.00131	0.00496	CbGeAlD
Quetiapine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00196	CcSEcCtD
Quetiapine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00196	CcSEcCtD
Quetiapine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00196	CcSEcCtD
Quetiapine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.0013	0.00491	CbGeAlD
Quetiapine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00195	CcSEcCtD
Quetiapine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.0013	0.0049	CbGeAlD
Quetiapine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.0013	0.00489	CbGeAlD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00194	CcSEcCtD
Quetiapine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00193	CcSEcCtD
Quetiapine—H1F0—cerebellum—amyotrophic lateral sclerosis	0.00128	0.00485	CbGeAlD
Quetiapine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00191	CcSEcCtD
Quetiapine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00189	CcSEcCtD
Quetiapine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00473	CbGeAlD
Quetiapine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00188	CcSEcCtD
Quetiapine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00124	0.00469	CbGeAlD
Quetiapine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00186	CcSEcCtD
Quetiapine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00185	CcSEcCtD
Quetiapine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00184	CcSEcCtD
Quetiapine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00184	CcSEcCtD
Quetiapine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00183	CcSEcCtD
Quetiapine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00182	CcSEcCtD
Quetiapine—CHRM5—brain—amyotrophic lateral sclerosis	0.00121	0.00457	CbGeAlD
Quetiapine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00181	CcSEcCtD
Quetiapine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00179	CcSEcCtD
Quetiapine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00175	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00171	CcSEcCtD
Quetiapine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0017	CcSEcCtD
Quetiapine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00168	CcSEcCtD
Quetiapine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00112	0.00423	CbGeAlD
Quetiapine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00167	CcSEcCtD
Quetiapine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00167	CcSEcCtD
Quetiapine—ADRA1B—brain—amyotrophic lateral sclerosis	0.0011	0.00417	CbGeAlD
Quetiapine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00165	CcSEcCtD
Quetiapine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00109	0.00413	CbGeAlD
Quetiapine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00109	0.00412	CbGeAlD
Quetiapine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00109	0.0041	CbGeAlD
Quetiapine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00163	CcSEcCtD
Quetiapine—ADRA1D—brain—amyotrophic lateral sclerosis	0.00108	0.00408	CbGeAlD
Quetiapine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00162	CcSEcCtD
Quetiapine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00162	CcSEcCtD
Quetiapine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0016	CcSEcCtD
Quetiapine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0016	CcSEcCtD
Quetiapine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00106	0.00399	CbGeAlD
Quetiapine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00397	CbGeAlD
Quetiapine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00105	0.00395	CbGeAlD
Quetiapine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00105	0.00395	CbGeAlD
Quetiapine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00395	CbGeAlD
Quetiapine—H1F0—brain—amyotrophic lateral sclerosis	0.00104	0.00394	CbGeAlD
Quetiapine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00103	0.00389	CbGeAlD
Quetiapine—DRD1—brain—amyotrophic lateral sclerosis	0.00103	0.00389	CbGeAlD
Quetiapine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00155	CcSEcCtD
Quetiapine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00153	CcSEcCtD
Quetiapine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00102	0.00384	CbGeAlD
Quetiapine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00101	0.00381	CbGeAlD
Quetiapine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.001	0.00378	CbGeAlD
Quetiapine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.000999	0.00377	CbGeAlD
Quetiapine—HTR3A—brain—amyotrophic lateral sclerosis	0.000995	0.00376	CbGeAlD
Quetiapine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.000988	0.00373	CbGeAlD
Quetiapine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00148	CcSEcCtD
Quetiapine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00148	CcSEcCtD
Quetiapine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.000952	0.00359	CbGeAlD
Quetiapine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00138	CcSEcCtD
Quetiapine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.000918	0.00347	CbGeAlD
Quetiapine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000913	0.00345	CbGeAlD
Quetiapine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000895	0.00135	CcSEcCtD
Quetiapine—CHRM3—nervous system—amyotrophic lateral sclerosis	0.000885	0.00334	CbGeAlD
Quetiapine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00133	CcSEcCtD
Quetiapine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000881	0.00333	CbGeAlD
Quetiapine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00128	CcSEcCtD
Quetiapine—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.000852	0.00322	CbGeAlD
Quetiapine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000848	0.0032	CbGeAlD
Quetiapine—HTR7—nervous system—amyotrophic lateral sclerosis	0.000842	0.00318	CbGeAlD
Quetiapine—HTR1B—brain—amyotrophic lateral sclerosis	0.000834	0.00315	CbGeAlD
Quetiapine—CHRM2—brain—amyotrophic lateral sclerosis	0.00083	0.00313	CbGeAlD
Quetiapine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000829	0.00313	CbGeAlD
Quetiapine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000825	0.00124	CcSEcCtD
Quetiapine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000822	0.0031	CbGeAlD
Quetiapine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000812	0.00307	CbGeAlD
Quetiapine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.000811	0.00306	CbGeAlD
Quetiapine—HTR1D—brain—amyotrophic lateral sclerosis	0.000808	0.00305	CbGeAlD
Quetiapine—HTR2C—brain—amyotrophic lateral sclerosis	0.0008	0.00302	CbGeAlD
Quetiapine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000796	0.00301	CbGeAlD
Quetiapine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000794	0.00119	CcSEcCtD
Quetiapine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000792	0.00299	CbGeAlD
Quetiapine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000787	0.00118	CcSEcCtD
Quetiapine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000786	0.00118	CcSEcCtD
Quetiapine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000782	0.00295	CbGeAlD
Quetiapine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000782	0.00117	CcSEcCtD
Quetiapine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000774	0.00292	CbGeAlD
Quetiapine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000766	0.00289	CbGeAlD
Quetiapine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000764	0.00289	CbGeAlD
Quetiapine—CHRM1—brain—amyotrophic lateral sclerosis	0.000756	0.00285	CbGeAlD
Quetiapine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000749	0.00283	CbGeAlD
Quetiapine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000745	0.00281	CbGeAlD
Quetiapine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000741	0.00111	CcSEcCtD
Quetiapine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000733	0.00277	CbGeAlD
Quetiapine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000728	0.00275	CbGeAlD
Quetiapine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000717	0.00271	CbGeAlD
Quetiapine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000699	0.00264	CbGeAlD
Quetiapine—CHRM3—brain—amyotrophic lateral sclerosis	0.000676	0.00255	CbGeAlD
Quetiapine—HTR1A—brain—amyotrophic lateral sclerosis	0.000673	0.00254	CbGeAlD
Quetiapine—HTR7—brain—amyotrophic lateral sclerosis	0.000644	0.00243	CbGeAlD
Quetiapine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000629	0.00237	CbGeAlD
Quetiapine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000623	0.00235	CbGeAlD
Quetiapine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000621	0.00234	CbGeAlD
Quetiapine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000618	0.00233	CbGeAlD
Quetiapine—DRD2—brain—amyotrophic lateral sclerosis	0.000608	0.0023	CbGeAlD
Quetiapine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000605	0.00229	CbGeAlD
Quetiapine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000595	0.00225	CbGeAlD
Quetiapine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000592	0.00223	CbGeAlD
Quetiapine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000581	0.00219	CbGeAlD
Quetiapine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000525	0.00198	CbGeAlD
Quetiapine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000506	0.00191	CbGeAlD
Quetiapine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000494	0.00187	CbGeAlD
Quetiapine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000486	0.00184	CbGeAlD
Quetiapine—HRH1—brain—amyotrophic lateral sclerosis	0.000481	0.00181	CbGeAlD
Quetiapine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000478	0.00181	CbGeAlD
Quetiapine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000472	0.00178	CbGeAlD
Quetiapine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000468	0.00177	CbGeAlD
Quetiapine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000461	0.00174	CbGeAlD
Quetiapine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000458	0.00173	CbGeAlD
Quetiapine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00045	0.0017	CbGeAlD
Quetiapine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000408	0.00154	CbGeAlD
Quetiapine—HTR2A—brain—amyotrophic lateral sclerosis	0.000401	0.00152	CbGeAlD
Quetiapine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000366	0.00138	CbGeAlD
Quetiapine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000344	0.0013	CbGeAlD
Quetiapine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000331	0.00125	CbGeAlD
Quetiapine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000324	0.00122	CbGeAlD
Quetiapine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.000322	1	CrCbGaD
Quetiapine—ABCB1—brain—amyotrophic lateral sclerosis	0.000263	0.000993	CbGeAlD
Quetiapine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.66e-05	0.00024	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.66e-05	0.00024	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.66e-05	0.000239	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.65e-05	0.000238	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.63e-05	0.000235	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.63e-05	0.000235	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.63e-05	0.000235	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.62e-05	0.000234	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.62e-05	0.000233	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.62e-05	0.000233	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.61e-05	0.000232	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.61e-05	0.000232	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.6e-05	0.000231	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.6e-05	0.00023	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.6e-05	0.00023	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.6e-05	0.00023	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.58e-05	0.000228	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.58e-05	0.000228	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.57e-05	0.000225	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.56e-05	0.000225	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.56e-05	0.000224	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.55e-05	0.000224	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.000223	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.55e-05	0.000223	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.54e-05	0.000222	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.54e-05	0.000222	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	0.000222	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.53e-05	0.000221	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.53e-05	0.00022	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.52e-05	0.000219	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.52e-05	0.000219	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.5e-05	0.000216	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.5e-05	0.000216	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.49e-05	0.000215	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.49e-05	0.000215	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.49e-05	0.000215	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.49e-05	0.000214	CbGpPWpGaD
Quetiapine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	1.49e-05	0.000214	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000214	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.48e-05	0.000214	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.47e-05	0.000212	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.47e-05	0.000212	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.47e-05	0.000211	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.46e-05	0.00021	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000209	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000208	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.43e-05	0.000206	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	1.42e-05	0.000205	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.42e-05	0.000204	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.42e-05	0.000204	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000202	CbGpPWpGaD
Quetiapine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.39e-05	0.0002	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.39e-05	0.0002	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000199	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.38e-05	0.000199	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.37e-05	0.000197	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.37e-05	0.000197	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.000196	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.36e-05	0.000196	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.35e-05	0.000195	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.33e-05	0.000192	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.33e-05	0.000192	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.33e-05	0.000192	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.33e-05	0.000191	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.33e-05	0.000191	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.33e-05	0.000191	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.32e-05	0.000191	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.32e-05	0.00019	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.32e-05	0.00019	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.31e-05	0.000188	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.3e-05	0.000188	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.29e-05	0.000186	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.28e-05	0.000185	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.27e-05	0.000184	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.27e-05	0.000183	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.27e-05	0.000183	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.000183	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.26e-05	0.000181	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.25e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.00018	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.00018	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.00018	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000179	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000179	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.24e-05	0.000179	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000178	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000177	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000177	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.000176	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000176	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.22e-05	0.000176	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.21e-05	0.000175	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.2e-05	0.000173	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000172	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.19e-05	0.000171	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.17e-05	0.000169	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000166	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.15e-05	0.000165	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	0.000164	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.14e-05	0.000164	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.13e-05	0.000163	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.13e-05	0.000163	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.13e-05	0.000162	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.13e-05	0.000162	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.12e-05	0.000162	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000161	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.11e-05	0.000159	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.1e-05	0.000159	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.1e-05	0.000159	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.1e-05	0.000158	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.09e-05	0.000157	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.08e-05	0.000156	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.05e-05	0.000151	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000151	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000148	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000148	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000148	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.02e-05	0.000148	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000148	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.02e-05	0.000148	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.02e-05	0.000147	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000147	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.02e-05	0.000147	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.02e-05	0.000146	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000146	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000145	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.01e-05	0.000145	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.96e-06	0.000143	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.85e-06	0.000142	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.8e-06	0.000141	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.8e-06	0.000141	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.74e-06	0.00014	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.68e-06	0.000139	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.67e-06	0.000139	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.66e-06	0.000139	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.66e-06	0.000139	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.65e-06	0.000139	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.62e-06	0.000139	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.61e-06	0.000138	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.53e-06	0.000137	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.45e-06	0.000136	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.42e-06	0.000136	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.41e-06	0.000136	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.38e-06	0.000135	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.37e-06	0.000135	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.26e-06	0.000133	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.26e-06	0.000133	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.13e-06	0.000132	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.88e-06	0.000128	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.82e-06	0.000127	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.75e-06	0.000126	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.7e-06	0.000125	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.7e-06	0.000125	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.69e-06	0.000125	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.68e-06	0.000125	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.65e-06	0.000125	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.63e-06	0.000124	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.51e-06	0.000123	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.51e-06	0.000123	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.49e-06	0.000122	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.47e-06	0.000122	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.45e-06	0.000122	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.44e-06	0.000122	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.37e-06	0.000121	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.36e-06	0.00012	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.33e-06	0.00012	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.33e-06	0.00012	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.31e-06	0.00012	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.22e-06	0.000118	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.22e-06	0.000118	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.2e-06	0.000118	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	7.94e-06	0.000114	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.86e-06	0.000113	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.85e-06	0.000113	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	7.75e-06	0.000112	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.74e-06	0.000112	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.68e-06	0.000111	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.58e-06	0.000109	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.54e-06	0.000109	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.48e-06	0.000108	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.42e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.38e-06	0.000106	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.38e-06	0.000106	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.34e-06	0.000106	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	7.3e-06	0.000105	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.22e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.17e-06	0.000103	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.13e-06	0.000103	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.04e-06	0.000101	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.93e-06	9.99e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.83e-06	9.83e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.67e-06	9.6e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.66e-06	9.59e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.57e-06	9.46e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.56e-06	9.45e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.55e-06	9.44e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.54e-06	9.42e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.52e-06	9.39e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.52e-06	9.39e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.5e-06	9.36e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.44e-06	9.27e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.43e-06	9.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.42e-06	9.24e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.4e-06	9.22e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.38e-06	9.2e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.31e-06	9.1e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.29e-06	9.06e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.28e-06	9.05e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.23e-06	8.97e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.2e-06	8.93e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.19e-06	8.92e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.18e-06	8.9e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.16e-06	8.87e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.14e-06	8.84e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.13e-06	8.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.08e-06	8.76e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.06e-06	8.73e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.96e-06	8.59e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.93e-06	8.55e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.8e-06	8.36e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.65e-06	8.15e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.65e-06	8.14e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.63e-06	8.11e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.58e-06	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.58e-06	8.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.56e-06	8.01e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.55e-06	7.99e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.53e-06	7.97e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.51e-06	7.94e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.46e-06	7.86e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.44e-06	7.84e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.44e-06	7.84e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.31e-06	7.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.06e-06	7.29e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.04e-06	7.26e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5e-06	7.21e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.86e-06	7.01e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.84e-06	6.97e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	4.77e-06	6.88e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.71e-06	6.78e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.63e-06	6.67e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.27e-06	6.15e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.2e-06	6.05e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.19e-06	6.04e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.18e-06	6.02e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.16e-06	6e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.12e-06	5.94e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.11e-06	5.93e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.82e-06	5.51e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.27e-06	4.71e-05	CbGpPWpGaD
